CytoMed Therapeutics Ltd (GDTC)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current GDTC market cap is 30.47M. The company's latest EPS is SGD -0.3581 and P/E is -7.37.
| Quarter End | ||||
|---|---|---|---|---|
| SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
| Total Revenue | ||||
| Operating Income | ||||
| Net Income |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
| Total Revenue | 127.46M | 151.24M | 484k | 518k |
| Operating Income | -1.26B | -1.94B | -1.49M | -3.87M |
| Net Income | -1.94B | -2.05B | -3.13M | -4.13M |
| Quarter End | ||||
|---|---|---|---|---|
| SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
| Total Assets | ||||
| Total Liabilities | ||||
| Total Equity |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
| Total Assets | 3.82B | 6.08B | 5.23M | 12.37M |
| Total Liabilities | 3.34B | 3.49B | 4.64M | 1.13M |
| Total Equity | 475.78M | 2.59B | 586k | 11.24M |
| Market Cap | 30.47M |
| Price to Earnings Ratio | -7.37 |
| Price to Sales Ratio | 58.8 |
| Price to Cash Ratio | 3.39 |
| Price to Book Ratio | 2.71 |
| Dividend Yield | - |
| Shares Outstanding | 11.54M |
| Average Volume (1 week) | 16.65k |
| Average Volume (1 Month) | 688.67k |
| 52 Week Change | -24.57% |
| 52 Week High | 4.0499 |
| 52 Week Low | 1.20 |
| Spread (Intraday) | 0.3 (11.32%) |
| Company Name | CytoMed Therapeutics Ltd |
| Address |
#08-22 one commonwealth singapore 149544 |
| Website | https://www.cytomed.sg. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
